… to the West Pharmaceutical Services first quarter 2025 Earnings Conference … 1% in Q1 2024. Proprietary Products first quarter gross … repurchases, our capital expenditures offset by cash … the first quarter, foreign currency improvement, and the first quarter …

… Inc. (NYSE:HCA) Q1 2025 Earnings Call Transcript April … the first quarter of 2025 included $991 million in capital expenditures, $ … tariffs, such as pharmaceuticals. As I’ve noted, … at the first quarter of 2025 compared to the first quarter of 2024 …

… first quarter ended March 31, 2025. Key first quarter … During the first quarter of 2025, capital expenditures totaled $ … the first quarter of 2024. During the first quarter of … other expenditures; workforce disruptions; supply and pharmaceutical shortages …

… costs in the first quarter primarily through unfavorable … markets persisted in the first quarter. Environmental & … including household, food and pharmaceutical, paper, packaging, automotive, … from operations less capital expenditures. The following is …

First Quarter Highlights† Reported revenue of $355.4 million, up 9.8% Constant currency revenue* and constant currency revenue, organic* up 10.9% and up 6.0%, respectively GAAP operating margin of 11.5%, compared to 11.1% in prior year period Non-GAAP …

… EPS exceeded our first quarter guidance. We are … expenditures) was $58.1 million, an increase from the first quarter … the accompanying tables. WEST PHARMACEUTICAL SERVICES, INC. CONSOLIDATED … /west-announces-first-quarter-2025-results-increases-adjusted …

… financial results for its first quarter ended March 29, 2025 … .” First Quarter 2025 Results Net sales for the first quarter of … a leading online pet pharmacy, in its family of … flows from investing activities:       Capital expenditures   (141,280 )     (157, …

… and solid first quarter cash flows.” First Quarter 2025 Financial … strategically, with record Q1 financial results and … food, supplement and pharmaceutical industries. The Animal … activities:         Capital expenditures and intangible assets acquired     …

… Appreciate you joining our first quarter 2025 earnings call. … first quarter earnings call. We had a strong Q1 … pharmaceutical sector tariffs. In summary, our strong performance in the first quarter … terms of committed capital expenditure going forward? And …

… Inc. (NYSE:DOW) Q1 2025 Earnings Call Transcript April … energy, home care, and pharma end markets. Data centers, … approaching a big capital expenditure for a lifetime extension … second quarter relative to the first quarter, pertains to downstream siloxanes. …